BACKGROUND: Behçet's disease (BD) is a rare condition with a classic triad of oral and genital ulceration and eye disease. Cardiovascular complication is a rare finding in BD.
Introduction
Behçet's disease (BD) is a rare condition with a classic triad of oral and genital ulceration and eye disease. The other manifestations of BD are rare and include cardiovascular, gastrointestinal, musculoskeletal and central nervous systems. 1 Intracardiac thrombosis is a rare and serious complication that can occur in half of the BD cases although cardiac involvement is not common. 2 The management of this complication is difficult due to recurrence even after surgical resection of the thrombus. Intracardiac thrombosis is a rare complication of BD which has not been established much in the literature. We report here a case of BD who had thrombosis in right ventricle (RV) due to BD.
Case Report
In March 2015, a 17-year-old man was referred to our hospital by infectious disease specialists for the evaluation of fever for over 20 days. He was treated for viral infection at first by infectious disease specialists. Then antibiotic therapy was conducted due to painful oral and skin lesions on scrotum. Patient suffered from bilateral vision loss and photophobia initiated 3 days before admission to hospital. His body temperature was 38.8 °C, systolic/diastolic blood pressure was 115/70 mmHg and heart rate was 96 bpm when physically examined.
The heart sounds were normal without any murmurs and the lung fields were clear to auscultation. The electrocardiogram showed normal sinus rhythm. The chest X ray was normal. We noted an inflammatory syndrome in the laboratory results (white blood cell count: 113,000 mm 3 , neutrophil: 60%, C-reactive protein: 62 mg/l, erythrocyte sedimentation rate: 71 mm/hour). Therefore, antibiotics were started due to endocarditis. Blood cultures and serology tests for fever, Legionella, Bartonella, Tropheryma whipplei, Chlamydia, Mycoplasma, and Brucella were negative. The transthoracic echocardiography (TTE) showed a left ventricle ejection fraction of about 65% and a mobile mass seen in RV apex which was hyperechoic and well circumscribed ( Figure 1) .
A thoracic multi detector computed tomography (MDCT) confirmed the diagnosis of bilateral segmental pulmonary thromboembolism (PTE) and infarction. A transesophageal echocardiogram (TEE) did not show the nature of RV mass. Three differential diagnosis were introduced for RV mass including fever including infection, malignancy and clot. Thus, cardiac magnetic resonance imaging (MRI) was performed and showed that the nature of mass was clot in RV trabeculae (Figure 2 Oral ulcers had a nonspecific pathology with a variable infiltrate of lymphocytes, macrophages, and neutrophils at the base of the ulcer that showed autoimmune disorder in histopathologic examination. We started treatment with anticoagulant since the patient was at risk of PTE and RV clot caused by leukocytoclastic and lymphocytic vasculitis which may also be seen in severe inflammation. The thrombophilia study did not show any abnormalities, and antinuclear antibody, anti-DNA antibody, anti-extractable nuclear antigen (anti-ENA) antibody, and antineutrophil cytoplasmic antibody tests and tumor markers were all negative. We noted a positive HLA-B51 and HLA-B5 serologic typing. Taking these findings together, the patient was diagnosed with BD. Corticosteroid (methylprednisolone 1 g per day for 3 days and followed by oral prednisone 1 mg/kg) with cyclophosphamide (1 gram monthly) treatment was started. In addition, warfarin was administered to maintain the international normalized ratio (INR) at 2.5 or above. Two months later, the RV clot had disappeared on TTE.
Discussion
Behçet's syndrome has been known since Hulusi Behçet, a Turkish dermatologist, described the triple symptom-complex including orogenital ulcerations and iritis with hypopyon. 3 Although, the prevalence of vascular involvement in BD varies from 7.7% to 43%, vascular involvement is very important in BD due to serious complications and death. 4 The underlying pathological mechanism of thrombosis among BD patients is not well known. Several causal factors have been established including endothelial cell disruption, antiphospholipid antibodies, 5-7 deficiencies of protein S, protein C, and antithrombin, 8 increase in von Willebrand factor antigen levels, 9 and fibrinolysis abnormalites 10 which increase the risk of thrombosis in BD patients. Arachidonic acid metabolism plays an important role in the process of hemostasis and thrombosis. Stimulation of endothelium and platelets results in formation of eicosanoid derivatives including thromboxane B2 (TXB2) and 6-keto-prostaglandin Fl alpha (PGFla). 11 Thrombosis in veins and arteries is one of the most frequent complications in BD which is associated with ocular involvement. 12 Cardiac involvement can be find in 1 to 5 percent of clinical series. 13 Only 50 cases had been reported with intracardiac thrombi which is a very rare complication. 14, 15 This condition is often associated with deep vein and vena cava thrombosis (50% and 22% of cases, respectively), 5 and pulmonary complications including pulmonary artery aneurysm or pulmonary embolism were also found. [16] [17] [18] Intracardiac thrombosis usually involves the right side of the heart in 78% of cases, [19] [20] [21] [22] however some studies 23, 24 have reported left ventricle involvement. In our patient, the thrombus was found in the right ventricle, like most of the studies.
Transesophageal and transthoracic echocardiography are appropriate methods for the diagnosis of cardiac thrombosis which show a mass, heterogeneous and echogenic 25 that could also be seen in intracardiac tumors such as a myxoma or endomyocardial fibrosis. 16 Imaging tests such as chest computer tomography (CT) and MRI could be helpful in the assessment of thoracic manifestations of BD including thrombus of the systemic veins, heart and pulmonary arteries.
In the present observation, the diagnosis of the thrombus was obvious on cardiac MRI. Lack of pathognomonic symptoms and diagnostic laboratory tests makes BD difficult to diagnosis. In addition to performing lab tests and imaging, epidemiologic data should also be evaluated such as residing in Mediterranean area, young age and male sex, which increase the risk of BD. The aim of intracardiac thrombosis treatment is to control the underlying disease and resolve the thrombus. Anticoagulant and antithrombotic agents are the first line of therapy. 7 Surgery might become necessary in cases of massive or recurrent cardiac thrombosis. 2 In the case presented here, we found that Behçet's syndrome was controlled by immunosuppressive drugs and corticosteroids in our patient.
As a conclusion, one of the possible complications of BD is the thrombosis of the right heart cavities that can lead to pulmonary embolism. Early cardiac MRI and echocardiography should be performed to detect cardiac involvement, and medical treatment is the first choice of treatment.
